Page last updated: 2024-09-05

xv 459 and cardiovascular agents

xv 459 has been researched along with cardiovascular agents in 1 studies

Compound Research Comparison

Studies (xv 459)	Trials (xv 459)	Recent Studies (post-2010) (xv 459)	Studies (cardiovascular agents)	Trials (cardiovascular agents)	Recent Studies (post-2010) (cardiovascular agents)
15	2	0	17,645	1,480	6,891

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Christ, DD; Diamond, S; Gan, L; Mutlib, AE; Nemeth, G; Shockcor, J; Way, R	1

Other Studies

1 other study(ies) available for xv 459 and cardiovascular agents

Article	Year
Mass spectrometric and NMR characterization of metabolites of roxifiban, a potent and selective antagonist of the platelet glycoprotein IIb/IIIa receptor. Xenobiotica; the fate of foreign compounds in biological systems, 2000, Volume: 30, Issue:11 Topics: Amidines; Amino Acids; Animals; Cardiovascular Agents; Chromatography, High Pressure Liquid; Dogs; Feces; Gas Chromatography-Mass Spectrometry; Humans; Isoxazoles; Liver; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Thrombosis	2000

Article

Year

Mass spectrometric and NMR characterization of metabolites of roxifiban, a potent and selective antagonist of the platelet glycoprotein IIb/IIIa receptor.

Xenobiotica; the fate of foreign compounds in biological systems, 2000, Volume: 30, Issue:11

Topics: Amidines; Amino Acids; Animals; Cardiovascular Agents; Chromatography, High Pressure Liquid; Dogs; Feces; Gas Chromatography-Mass Spectrometry; Humans; Isoxazoles; Liver; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Thrombosis

2000